A Phase 2 Study of Sitravatinib in Combination With PD-(L)1 Checkpoint Inhibitor Regimens in Patients With Advanced or Metastatic Urothelial Carcinoma

Name: A Phase 2 Study of Sitravatinib in Combination With PD-(L)1 Checkpoint Inhibitor Regimens in Patients With Advanced or Metastatic Urothelial Carcinoma
License: Public Domain

Mirati Therapeutics Inc.

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

urothelial carcinoma, urothelial carcinoma bladder, urothelial carcinoma ureter, urothelial carcinoma of the renal pelvis and ureter, urothelial carcinoma urethra

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 217004
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.